Press Releases
Summit Therapeutics and MD Anderson announce strategic collaboration to accelerate development of Ivonescimab
Summit Therapeutics and The University of Texas MD Anderson Cancer Center (MD Anderson) today announced a strategic five-year collaboration agreement…
Autobahn Therapeutics completes oversubscribed $100m Series C financing to advance pipeline of Novel Therapeutics for depression and other CNS disorders
Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the closing…
Pinetree Therapeutics announces exclusive option and global license agreement for preclinical EGFR degrader candidate with AstraZeneca
Pinetree Therapeutics, a biotechnology company pioneering next generation targeted protein degraders (TPD) to combat drug resistance in oncology and beyond,…
Johnson & Johnson seeks U.S. FDA approval of SPRAVATO (esketamine) as the first and only monotherapy for adults with treatment-resistant depression
Johnson & Johnson (NYSE: JNJ) announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food…
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
STADA and Alvotech have launched Uzpruvo, the first approved biosimilar to Stelara in Europe, across a majority of European countries. This…
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX
SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services…
Everest Medicines announces first Chinese patient dosed in global Phase 2b PALIZADE trial of Zetomipzomib in Lupus Nephritis
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that…
Renalys Pharma closes ¥6.0bn series A financing to advance kidney disease treatments across Asia
Renalys Pharma, Inc., a late-stage clinical biopharmaceutical company has completed a ¥6.0Bn Series A financing. The financing was led by…
Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema study
Roche announced today new, four-year data from the RHONE-X extension study. The study met all primary endpoints, showing that Vabysmo (faricimab)…
Merck begins commercial production of first GMP-compliant manufacturing line for cell culture media in China
Merck, a leading science and technology company, today announced the start of commercial production of its first GMP (Good Manufacturing…